Home Immunis

Immunis

In operation
Series A
Developer of Immunodeficiency Treatment Methods

Basic Information

Immunis is a biotechnology company that focuses on developing treatments for age- and disease-related immune deficiencies. Immunis has developed a novel approach to cultivate human stem cells for clinical use and guide them into high-purity specific cell populations.
Immunis, Inc.
California,United States of America
15~50 people
January 01, 2019
contact@immunisbiomedical.com